Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer
Open Access
- 4 March 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Abstract
The targeting of cancer stem cells (CSCs) has proven to be an effective approach for limiting tumor progression, thus necessitating the identification of new drugs with anti-CSC activity. Through a high-throughput drug repositioning screen, we identify the antibiotic Nifuroxazide (NIF) as a potent anti-CSC compound. Utilizing a click chemistry strategy, we demonstrate that NIF is a prodrug that is specifically bioactivated in breast CSCs. Mechanistically, NIF-induced CSC death is a result of a synergistic action that combines the generation of DNA interstrand crosslinks with the inhibition of the Fanconi anemia (FA) pathway activity. NIF treatment mimics FA-deficiency through the inhibition of STAT3, which we identify as a non-canonical transcription factor of FA-related genes. NIF induces a chemical HRDness (Homologous Recombination Deficiency) in CSCs that (re)sensitizes breast cancers with innate or acquired resistance to PARP inhibitor (PARPi) in patient-derived xenograft models. Our results suggest that NIF may be useful in combination with PARPi for the treatment of breast tumors, regardless of their HRD status.Keywords
All Related Versions
Funding Information
- Ligue Contre le Cancer (label 2021)
- Fondation Bettencourt Schueller
- Canceropôle PACA
- Fondation ARC pour la Recherche sur le Cancer
This publication has 83 references indexed in Scilit:
- Genome-wide RNA interference screen in cancer stem cells2022
- A Strategy Based on Aggregation‐Induced Ratiometric Emission to Differentiate Molecular Weight of Supramolecular PolymersAngewandte Chemie International Edition, 2022
- Synthesis and characterization of novel poly(arylene ether)s containing 1,3,4-oxadiazole and triazole units through click chemistryMacromolecular Research, 2015
- Genome-Scale CRISPR-Mediated Control of Gene Repression and ActivationCell, 2014
- Anti-tubercular agents. Part 8: Synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazolesBioorganic & Medicinal Chemistry Letters, 2013
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh CellsCancer Cell, 2013
- Residue depletion of nifuroxazide in broiler chickenJournal of the Science of Food and Agriculture, 2012
- Assessment of DNA Interstrand Crosslinks Using the Modified Alkaline Comet Assay2011
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009
- Mutagenicity of nitrofuran derivatives: ReviewEnvironmental Mutagenesis, 1983